n-Docosanol 10% cream in the treatment of recurrent herpes labialis: a randomised, double-blind, placebo-controlled study

Habbema, L; De Boulle, K; Roders, GA; Katz, DH

HERO ID

4929588

Reference Type

Journal Article

Year

1996

Language

English

PMID

8982417

HERO ID 4929588
In Press No
Year 1996
Title n-Docosanol 10% cream in the treatment of recurrent herpes labialis: a randomised, double-blind, placebo-controlled study
Authors Habbema, L; De Boulle, K; Roders, GA; Katz, DH
Journal Acta Dermato-Venereologica
Volume 76
Issue 6
Page Numbers 479-481
Abstract n-Docosanol has been shown to have antiviral activity. To demonstrate the efficacy of n-docosanol 10% cream in the treatment of recurrent herpes labialis, a randomised, double-blind, parallel group, placebo-controlled study was undertaken in 63 patients. In a crossover extension, 22 of the patients used the alternative treatment for a further episode. A total of 98 episodes were evaluated. Application of n-docosanol 10% cream early in the prodromal or erythema stage of a recurrent episode of herpes labialis shortened mean healing time by approximately 3 days, as compared to late treatment with n-docosanol 10% cream and early or late treatment with the placebo. The crossover study revealed that late treatment with n-docosanol 10% cream significantly reduced mean healing time compared to placebo. Treatments were well tolerated.
Pmid 8982417
Wosid WOS:A1996VW02300018
Is Certified Translation No
Dupe Override No
Is Public Yes
Language Text English
Keyword antiviral; cold sore; topical application
Relationship(s)